Dr. Dali Shukla

Insightful professional in higher education, known for high productivity and efficient task completion. Skilled in curriculum development, innovative instructional strategies, and academic research. Excel in communication, critical thinking, and adaptability, ensuring effective teaching methodologies and positive student outcomes.

Indian Pharmacy Graduate Association, New Delhi

• AU-CBT Excellence award, 2009, Biotech Research Society, INDIA (BRSI)
• Publication Scholarship Award, 2011, IT BHU Alumni Association
• Publication Scholarship Award, 2012, IT BHU Alumni Association
• Travel Fellowship, 2009, Department of Biotechnology (DBT), New Delhi and Centre for Cooperation in Science and Technology among Developing Societies (CCSTDS), Chennai
• UGC Summer/Winter Training Programme, 2010, Panjab University, Chandigarh
• High Performance High Potential candidate, 2007, Lupin Research Park, Pune
• GATE 2003, 99.69, All India Rank: 20
• ICMR Senior Research Fellowship, 09/01/09 to 08/31/11
• UGC Research Fellowship, 02/01/08 to 08/31/09
• UGC Junior Research Fellowship, During M. Pharm.
• National Scholarship, Matriculation

Formulation and evaluation of mouth dissolving tablets of risperidone involving various taste masking approaches, Sandoz Pvt. Ltd., Thane, 09/01/04 to 05/31/05, Prof. B. Mishra (Deptt. of Pharmaceutics, IT, BHU), Mr. Sunil B. Roy (Head, Zydus Cadila, Ahmedabad)

Development and evaluation of oral modified release multiparticulate drug delivery system using pastillation technology, Department of Pharmaceutics, Indian Institute of Technology(BHU), Varanasi, 02/01/08 to 08/31/11, Dr. B. Mishra (Professor and Head, Deptt. of Pharmaceutics, IT, BHU)

• Revealing facts behind spray dried solid dispersion technology used for solubility enhancement, BB Patel, JK Patel, S Chakraborty, D Shukla, Saudi Pharmaceutical Journal, 2013, 0.662, 1
• Evaluation of in vivo behavior of controlled and pulsatile release pastilles using pharmacokinetic and γ-scintigraphic techniques, D Shukla, S Chakraborty, B Mishra, Expert Opinion on Drug Delivery, 9, 10, 1333–1345, 2012, 4.896, -
• In vitro and in vivo evaluation of multilayered pastilles for chronotherapeutic management of nocturnal asthma, D Shukla, S Chakraborty, B Mishra, Expert Opinion on Drug Delivery, 9, 1, 9-18, 2012, 4.896, 2
• Pastillation: A novel technology for development of oral lipid based multiparticulate controlled release formulation, D Shukla, S Chakraborty, S Singh, B Mishra, Powder Technology, 209, 1-3, 65-72, 2011, 2.080, 6
• Lipid based oral multiparticulate formulations – Advantages, technological advances and industrial applications, D Shukla, S Chakraborty, S Singh, B Mishra, Expert Opinion on Drug Delivery, 8, 2, 207-24, 2011, 4.896, 20
• Doxofylline: A promising methylxanthine derivative for the treatment of asthma and chronic obstructive pulmonary disease, D Shukla, S Chakraborty, S Singh, B Mishra, Expert Opinion on Pharmacotherapy, 10, 14, 2343-56, 2009, 3.205, 20
• Effective in-vivo utilization of lipid based nanoparticles as drug carrier for carvedilol phosphate, S Chakraborty, D Shukla, PR Vuddanda, B Mishra, S Singh, Journal of Pharmacy and Pharmacology, 63, 6, 774-9, 2011, 2.175, 1
• Utilization of adsorption technique in the development of oral delivery system of lipid based nanoparticles, S Chakraborty, D Shukla, PR Vuddanda, B Mishra, S Singh, Colloid and Surface: Biointerface, 81, 2, 563-9, 2010, 3.456, 17
• Clinical updates on carvedilol: A first choice b-blocker in the treatment of cardiovascular diseases, S Chakraborty, D Shukla, B Mishra, S Singh, Expert Opinion on Drug Metabolism and Toxicology, 6, 2, 237-50, 2010, 3.119, 22
• Lipid - An emerging platform for oral delivery of drugs with poor bioavailability, S Chakraborty, D Shukla, B Mishra, S Singh, European Journal of Pharmaceutics and Biopharmaceutics, 73, 1, 1-15, 2009, 4.269, 133
• Assessment of solubilization characteristics of different surfactants for carvedilol phosphate as a function of pH, S Chakraborty, D Shukla, A Jain, B Mishra, S Singh, Journal of Colloid and Interface Science, 335, 2, 242-9, 2009, 3.070, 30
• Fabrication and evaluation of taste masked resinate of risperidone and its orally disintegrating tablets, D Shukla, S Chakraborty, S Singh, B Mishra, Chemical and Pharmaceutical Bulletin, 57, 4, 337-45, 2009, 1.592, 28
• Preparation and in-vitro characterization of Risperidone-cyclodextrin inclusion complexes as a potential injectable product, D Shukla, S Chakraborty, S Singh, B Mishra, DARU, 17, 4, 226-235, 2009, 0.625, 7
• Mouth dissolving tablets I: An overview of formulation technology, D Shukla, S Chakraborty, S Singh, B Mishra, Scientia Pharmaceutica, 77, 2, 309-26, 2009, -, 104
• Mouth dissolving tablets II: An overview of evaluation techniques, D Shukla, S Chakraborty, S Singh, B Mishra, Scientia Pharmaceutica, 77, 2, 327-41, 2009, -, 65
• Taste masking in oral drug delivery systems: A technological update, D Shukla, R Tripathi, B Mishra, The Pharmstudent, 25, 1, 58-64, 2010, -, -
• Investigation of organoleptic characteristics in the development of soft chews of calcium carbonate as mineral supplement, B Mishra, G Sharma, D Shukla, Yakugaku Zasshi, 129, 12, 1537-44, 2009, 0.389, 1
• Design of a controlled release liquid formulation of lamotrigine, B Mishra, D Panigrahi, M Mishra, D Shukla, DARU, 19, 2, 126-37, 2011, 0.625, 4
• Matrix based extended release tablet of an antihyperlipidemic drug: design and development, B Mishra, D Shukla, Inventi Impact: NDDS, Inventi:pndds/220/11, 2011, -, -

• Design and evaluation of multilayered pastilles for chronotherapeutic management of nocturnal asthma, Shukla D, Chakraborty S, Yadav S, Mishra B, 11th international symposium on advances in technology and business potential of new drug delivery systems, Controlled Release Society, Indian Local Chapter (CRS-2011), Mumbai, 02/01/11
• Immobilization of Solid Lipid Nanoparticles for Improved Stability and Flow Property, Chakraborty S, Shukla D, Singh S, 3rd Annual Nanotechnology Symposium, Sullivan University, Kentucky, USA, 09/24/10
• Pastillation – A Novel Technology for Development of Oral Lipid Based Multiparticulate Controlled Release Dosage Form, Shukla D, Chakraborty S, Singh S and Mishra B, Annual conference of Australasian Pharmaceutical Sciences Association (APSA-2009), Hobart, Australia, 12/01/09
• Influence of Dispersion Media Composition in the Development of Stearic Acid Based Solid Lipid Nanoparticles, Chakraborty S, Shukla D, Mishra B and Singh S, Annual conference of Australasian Pharmaceutical Sciences Association (APSA-2009), Hobart, Australia, 12/01/09
• Risperidone cyclodextrin complex for dry powder injection: Formulation and characterization, Shukla D and Mishra B, International conference on Emerging Trends in Biotechnology (ETBT-2009), Varanasi, India, 12/01/09
• Taste masked resinate of risperidone- fabrication and evaluation, Shukla D, Patel BB, Srivastava AK and Mishra B, 60th Indian Pharmaceutical Congress (IPC-2008), New Delhi, 12/01/08
• Effect of fructose and other variables on release characteristics of Naproxen Sodium from osmotic pump tablets, Kumar P, Shukla D, Singh S, Shrivastava AK and Mishra B, 6th International Symposium on Advances in Technology and Business Potential of NDDS, Controlled Release Society, Indian Local Chapter (CRS-2005), Mumbai, 02/01/05
• Solubility enhancement of rofecoxib by β-cyclodextrin complexation and formulation and evaluation of tablets thereof, Mishra B, Singh I, Shukla D, Srivastava AK and Singh S, 56th Indian Pharmaceutical Congress (IPC-2004), Kolkata, 12/01/04

• Singing
• Listening music
• Sudoku

• Husband's Name: Dr. Subhashis Chakraborty
• Date of Birth: 09/15/1980